Today: 29 January 2026
Subscribe
Browse Category

NASDAQ:NTLA News 2 January 2026 - 9 January 2026

CRISPR Therapeutics stock slides after CFO share-sale filing; JPM conference next

CRISPR Therapeutics stock slides after CFO share-sale filing; JPM conference next

New York, Jan 9, 2026, 15:11 EST — Regular session CRISPR Therapeutics AG shares slid on Friday, bucking a firmer broader market, after a regulatory filing flagged a chief financial officer’s share sale under a pre-arranged trading plan. (Reuters) The company’s CFO, Raju Prasad, exercised stock options for 29,700 common shares and sold 29,700 shares the same day at prices…
9 January 2026
········
CRISPR Therapeutics stock (CRSP) slips into 2026 as New Year’s Day shuts Wall Street — what investors watch next

CRISPR Therapeutics stock (CRSP) slips into 2026 as New Year’s Day shuts Wall Street — what investors watch next

NEW YORK, January 1, 2026, 18:59 ET — Market closed Shares of CRISPR Therapeutics AG ended the last trading session of 2025 down 1.4% at $52.44. U.S. stock markets were closed on Thursday for New Year’s Day, according to the NYSE holiday calendar. StockAnalysis The pullback matters because CRISPR heads into 2026 with its first commercial product still early in…
2 January 2026
········

Stock Market Today

  • Stocks Dive as Microsoft Triggers Broad Tech Sell-Off
    January 29, 2026, 12:32 PM EST. U.S. stock indexes tumbled sharply in trading after Microsoft Corp's earnings report sparked a wider sell-off in technology shares. The tech-heavy Nasdaq Composite led declines, dragging broader markets down. Investors reacted to cautious revenue forecasts and weaker-than-expected guidance from Microsoft, raising concerns about growth in the tech sector. The retreat exposed vulnerabilities in high-valuation stocks as traders reassessed those positioned for rapid expansion. Market participants are now monitoring upcoming earnings from other major tech companies for further signals. The sell-off underscores ongoing volatility amid mixed corporate results and lingering economic uncertainties.
Go toTop